Pharmacokinetic Considerations for Drugs Targeting the Central Nervous System (CNS)
<p id="p1">Pharmacokinetic considerations need to be taken into account for drugs targeting the central nervous system (CNS). For this reason, in the present chapter, the general pharmacokinetic considerations are described. The CNS comprises the brain and the spinal cord. Both structures are surrou...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2025
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/1229040 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Pharmacokinetic Considerations for Drugs Targeting the Central Nervous System (CNS)
- Optical Coherence Tomography Angiography (OCT-A): Emerging Landscapes in Neuro-Ophthalmology and Central Nervous System (CNS) Disorders
- Pharmacokinetic – Pharmacodynamic Considerations for Bovine Mastitis Treatment
- Principles of CNS drug development from test tube to patient /
- Critical pathways to success in CNS drug development /
- Crosstalk Between the Immune and Central Nervous Systems with Special Reference to Drug Development
- Pharmacokinetic Interactions of Antihypertensive Drugs with Citrus Juices